Chris possesses a unique combination of commercial strategy experience and advanced technical background over 15 years in regenerative medicine. Most recently, he was responsible for the cross-functional, strategic alignment for the launch of the first CBER-approved allogeneic living cellular product, GINTUIT™. He has his PhD and BS in Biomedical Engineering (Georgia Tech and Johns Hopkins, respectively), Minor in Management as well as leadership positions in international societies (TERMIS), journals (Tissue Engineering) and top-tier universities (Georgia Tech, Duke University). For more information, please go to www.ridgewoodconsultingservices.com.